Inherited platelet disorders.

[1]  G. Lippi,et al.  The Role Of von Willebrand Factor In Hemorrhagic And Thrombotic Disorders , 2007, Critical reviews in clinical laboratory sciences.

[2]  S. Watson,et al.  A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO , 2006, British journal of haematology.

[3]  M. Cattaneo,et al.  Congenital platelet disorders: overview of their mechanisms, diagnostic evaluation and treatment , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

[4]  F. Hill,et al.  Distinguishing between type 2B and pseudo‐von Willebrand disease and its clinical importance , 2006, British journal of haematology.

[5]  A. Nurden.  Qualitative disorders of platelets and megakaryocytes , 2005, Journal of thrombosis and haemostasis : JTH.

[6]  C. Higgins,et al.  A novel missense mutation in ABCA1 results in altered protein trafficking and reduced phosphatidylserine translocation in a patient with Scott syndrome. , 2005, Blood.

[7]  M. Cattaneo.  The P2 Receptors and Congenital Platelet Function Defects , 2005, Seminars in thrombosis and hemostasis.

[8]  H. White,et al.  Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GPIBA gene resulting in platelet-type von Willebrand disease. , 2004, Blood.

[9]  A. Savoia,et al.  Inherited Thrombocytopenias: Molecular Mechanisms , 2004, Seminars in thrombosis and hemostasis.

[10]  A. Rao,et al.  Inherited Defects in Platelet Signaling Mechanisms , 2004, Seminars in thrombosis and hemostasis.

[11]  W. Gahl,et al.  Molecular defects that affect platelet dense granules. , 2004, Seminars in thrombosis and hemostasis.

[12]  M. Morfini,et al.  Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey , 2004, Journal of thrombosis and haemostasis : JTH.

[13]  K. Kaushansky,et al.  Inherited thrombocytopenias: toward a molecular understanding of disorders of platelet production , 2004, Current opinion in pediatrics.

[14]  I. Ramasamy.  Inherited bleeding disorders: disorders of platelet adhesion and aggregation. , 2004, Critical reviews in oncology/hematology.

[15]  M. Murata,et al.  Identification of a novel point mutation in platelet glycoprotein Ibα, Gly to Ser at residue 233, in a Japanese family with platelet‐type von Willebrand disease , 2003, Journal of thrombosis and haemostasis : JTH.

[16]  M. Cattaneo.  Inherited platelet‐based bleeding disorders , 2003, Journal of thrombosis and haemostasis : JTH.

[17]  M. Ballmaier,et al.  Thrombopoietin Is Essential for the Maintenance of Normal Hematopoiesis in Humans , 2003, Annals of the New York Academy of Sciences.

[18]  J. Ware,et al.  Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Orkin,et al.  X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction. , 2002, Blood.

[20]  J. Kaplan,et al.  Chediak-Higashi syndrome: a clinical and molecular view of a rare lysosomal storage disorder. , 2002, Current molecular medicine.

[21]  A. Savoia,et al.  Inherited thrombocytopenias: from genes to therapy. , 2002, Haematologica.

[22]  W. Gahl,et al.  Hermansky-Pudlak Syndrome and Chediak-Higashi Syndrome: Disorders of Vesicle Formation and Trafficking , 2001, Thrombosis and Haemostasis.

[23]  Long T. Nguyen,et al.  Congenital thrombocytopenia and radio‐ulnar synostosis: a new familial syndrome , 2001, British journal of haematology.

[24]  J. White,et al.  Paris‐Trousseau syndrome platelets in a child with Jacobsen's syndrome , 2001, American journal of hematology.

[25]  P. Noris,et al.  Autosomal dominant macrothrombocytopenia in Italy is most frequently a type of heterozygous Bernard-Soulier syndrome. , 2001, Blood.

[26]  H. Ochs,et al.  Wiskott–Aldrich syndrome protein and platelets , 2000, Immunological reviews.

[27]  U Magrini,et al.  Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium. , 2000, Nature genetics.

[28]  W. Vainchenker,et al.  Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome. , 2000, Blood.

[29]  H. Ochs,et al.  Molecular biology of the Wiskott-Aldrich syndrome. , 2000, Reviews in immunogenetics.

[30]  Long T. Nguyen,et al.  Amegakaryocytic thrombocytopenia and radio-ulnar synostosis are associated with HOXA11 mutation , 2000, Nature Genetics.

[31]  John M. Maris,et al.  Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia , 1999, Nature Genetics.

[32]  A. Nurden.  Inherited Abnormalities of Platelets , 1999, Thrombosis and Haemostasis.

[33]  H. Ochs.  The Wiskott-Aldrich syndrome , 2001, The Israel Medical Association journal : IMAJ.

[34]  K. Devriendt,et al.  Velocardiofacial Syndrome Patients with a Heterozygous Chromosome 22q11 Deletion Have Giant Platelets , 1998, Pediatric Research.

[35]  M. Peters,et al.  Treatment of a Patient with Bernard-Soulier Syndrome and Recurrent Nosebleeds with Recombinant Factor VIIa , 1998, Thrombosis and Haemostasis.

[36]  S. Kanner,et al.  Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. , 1997, Blood.

[37]  C. Hayward.  Inherited disorders of platelet alpha-granules. , 1997, Platelets.

[38]  J. Miller,et al.  Platelet-type von Willebrand Disease , 1996, Thrombosis and Haemostasis.

[39]  L. Tengborn,et al.  A Patient with Glanzmann Thrombasthenia and Epistaxis Successfully Treated with Recombinant Factor Vila , 1996, Thrombosis and Haemostasis.

[40]  K. Fukutake,et al.  Platelets with 10% of the normal amount of glycoprotein VI have an impaired response to collagen that results in a mild bleeding tendency , 1995, British journal of haematology.

[41]  Weiss Hj.  Scott syndrome: a disorder of platelet coagulant activity. , 1994 .

[42]  J. Okita,et al.  Montreal platelet syndrome: a defect in calcium-activated neutral proteinase (calpain). , 1989, Blood.

[43]  R. Colman,et al.  Differential requirements for platelet aggregation and inhibition of adenylate cyclase by epinephrine. Studies of a familial platelet alpha 2-adrenergic receptor defect , 1988 .

[44]  K. Mann,et al.  Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet Factor V deficiency. , 1984, The Journal of clinical investigation.

[45]  A. Castella,et al.  Platelet-type von Willebrand's disease: characterization of a new bleeding disorder , 1982 .

[46]  G. Raccuglia.  Gray platelet syndrome. A variety of qualitative platelet disorder. , 1971, The American journal of medicine.